Advertisement
Screener

RIGEL PHARMACEUTICALS, INC. (RIGL) ROE

RIGEL PHARMACEUTICALS, INC. (RIGL) ROE

  • 2026-06-30: ROE 75.67%.
  • 2026-03-31: ROE 91.08%.
  • 2025-12-31: ROE 93.75%.
  • 2025-09-30: ROE 96.34%.

Complete source-backed roe history.

Available history
2015-12-31 to 2026-06-30
Data captured

Historical ROE

DateROE
2026-06-3075.67%
2026-03-3191.08%
2025-12-3193.75%
2025-09-3096.34%
2025-06-30119.39%
2025-03-31200.24%
2024-12-31531.78%
2024-09-30-26.52%
2024-06-3047.58%
2024-03-3162.52%
2023-12-3187.60%
2023-09-3076.73%
2023-06-30134.35%
2023-03-31184.13%
2022-12-31430.18%
2022-09-30416.53%
2022-06-302298.88%
2022-03-31-1248.29%
2021-12-31-58.98%
2021-09-30-29.21%
2021-06-30-11.35%
2021-03-3134.91%
2020-12-31-86.31%
2020-09-30-54.42%
2020-03-31-13.16%
2019-12-31-103.98%
2019-03-31-67.80%
2018-12-31-56.74%
2018-03-31-101.70%
2017-12-31-77.75%
2017-03-31-30.15%

Annual ROE

DateROE
2025-12-3193.75%
2024-12-31531.78%
2023-12-3187.60%
2022-12-31430.18%
2021-12-31-58.98%
2020-12-31-87.42%
2019-12-31-124.30%
2018-12-31-64.14%
2017-12-31-77.49%
2016-12-31-125.79%
2015-12-31-56.32%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Apnimed, Inc. (APMD)United States$0.899B
Theravance Biopharma, Inc. (TBPH)$0.885B16.40
Cryoport, Inc. (CYRX)United States$0.881B-21.29
ARDELYX, INC. (ARDX)United States$0.857B-22.86
Jade Biosciences, Inc. (JBIO)United States$0.936B-9.21
Avalo Therapeutics, Inc. (AVTX)United States$0.842B-9.74
Immix Biopharma, Inc. (IMMX)United States$0.837B-18.44
Obsidian Therapeutics, Inc. (OBX)United States$0.829B
LEXICON PHARMACEUTICALS, INC. (LXRX)United States$0.823B-17.48
Arbutus Biopharma Corp (ABUS)$0.965B6.19